FDA gives green signal to HealthPNX
Zebra Medical Vision- an Israel-based developer recently has received FDA’s approval to use Artificial Intelligence to scan and analyze chest X-rays. It will help identify pneumothorax which is the buildup of air inside the pleural cavity, caused by injury either to the lung or the chest wall. Usually, Pneumothorax is detected via chest X-rays, but it still remains difficult to diagnose. Called HealthPNX, it will benefit around 70,000 people affected in the U.S. by reducing the diagnostic time and accurate radiography results.
Advances in Cell Therapy for Diabetes
Semma Therapeutics– a Harvard-born startup has been successful in converting stem cells into insulin-producing beta-cells for treating Diabetes. A Study published in the journal Nature reveals that earlier, their simulations could only produce only 30% of the functioning beta-cells, but now the proportion has increased up to 80%. Scientist at Semma also developed other innovative methods to accelerate the number of functioning beta cells with the help of a protein only found in beta cells.
Stem Cells are the talk of town
Scientists at the Morgridge Institute for Research recently used Pluripotent Stem cells to grow Smooth Muscle cells and Arteries to help patients suffering from cardiovascular disease. They were also successful in identifying a new small drug RepSox, which can benefit patients undergoing Bypass surgery by reducing pain. The drug also holds the potential in lowering down the risk associated with Corrective Surgeries.
Viral Machinery is now out in open
Researchers at Harvard Medical School’s Blavatnik Institute have successfully uncovered the mechanism by which some of the deadly viruses (causing Lassa fever, La Crosse and Rift Valley fever, etc.,) replicate and cannibalise host body. The new findings yielded that the viral machinery can be targeted by inhibiting its progression or replication. This invites for new novel therapies which directly hampers the viral replication.